Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort.
暂无分享,去创建一个
C. van Broeckhoven | S. Engelborghs | R. Vandenberghe | P. D. De Deyn | M. Cruts | P. Cras | A. Michotte | A. Ivanoiu | M. Vandenbulcke | P. Santens | J. van der Zee | J. Versijpt | P. de Jonghe | Jean-Jacques Martin | O. Deryck | A. Sieben | J. D. De Bleecker | M. van den Broeck | K. Peeters | I. Gijselinck | T. van Langenhove | M. Mattheijssens | L. Dillen | V. Bäumer | C. Willems | S. Philtjens | Githa Maes | P. D. de Deyn | M. Van den Broeck | Christiana Willems | Veerle Bäumer | Maria Mattheijssens
[1] T. Ferman,et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 , 2011, Acta Neuropathologica.
[2] Andrew Kertesz,et al. Relationship between Frontotemporal Dementia and Corticobasal Degeneration/Progressive Supranuclear Palsy , 2004, Dementia and Geriatric Cognitive Disorders.
[3] J. Hardy,et al. Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. , 2012, Brain : a journal of neurology.
[4] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[5] C. van Broeckhoven,et al. The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum , 2012, Annals of medicine.
[6] S. Engelborghs,et al. Clinical heterogeneity in 3 unrelated families linked to VCP p.Arg159His , 2009, Neurology.
[7] D. Neary,et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. , 2012, Brain : a journal of neurology.
[8] S. Pereson,et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.
[9] Julie S Snowden,et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. , 2008, Brain : a journal of neurology.
[10] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[11] David T. Jones,et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 , 2012, Brain : a journal of neurology.
[12] Patrick Santens,et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. , 2008, Human molecular genetics.
[13] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[14] C. Broeckhoven,et al. The molecular basis of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum. , 2012 .
[15] B. Miller,et al. Classification of primary progressive aphasia and its variants , 2011, Neurology.
[16] A. Eisen,et al. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p , 2012, Acta Neuropathologica.
[17] T. Hortobágyi,et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS , 2011, Acta Neuropathologica.
[18] Nick C Fox,et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features , 2012, Alzheimer's & Dementia.
[19] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[20] H. Feldman,et al. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. , 2012, Brain : a journal of neurology.
[21] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[22] C. van Broeckhoven,et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. , 2006, Brain : a journal of neurology.
[23] John Q. Trojanowski,et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update , 2009, Acta Neuropathologica.
[24] M. Hallett,et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.
[25] Y. Pijnenburg,et al. The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. , 2012, Brain : a journal of neurology.
[26] F. Marrosu,et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. , 2012, Brain : a journal of neurology.
[27] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[28] H. Feldman,et al. Clinical and pathological features of familial frontotemporal dementia caused by C 9 ORF 72 mutation on chromosome 9 p , 2012 .
[29] M G Spillantini,et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. , 1999, Journal of neuropathology and experimental neurology.
[30] Andrew King,et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. , 2008, Brain : a journal of neurology.
[31] Catherine Lomen-Hoerth,et al. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.
[32] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[33] Irene Litvan,et al. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.
[34] A. Al-Chalabi,et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study , 2012, The Lancet Neurology.
[35] D. Kareken,et al. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family , 2007, Brain : a journal of neurology.